Literature DB >> 23113439

Perceived stigma and barriers to mental health care in Marines attending the Combat Operational Stress Control program.

Nausheen Momen1, Chris P Strychacz, Erik Viirre.   

Abstract

The Department of Defense is aggressively addressing combat stress reactions (CSRs) through comprehensive Combat/Operational Stress Control (COSC) briefings/programs and referral resources for the prevention, identification, and treatment of stress reactions. The purpose of this study was to develop and administer a survey to assess perceptions of CSRs and barriers to care which affect help-seeking behavior in Marines attending the COSC program. A sample of 553 U.S. Marine Corps Officers and Enlisted personnel from Air (44%), Logistics (38%), and Infantry (18%) communities were recruited for the survey. The results suggested that misconceptions and stigma about CSRs still persist in Marines. The findings reinforced the need to facilitate treatment utilization by focusing on mental health-related stigma as well as organizational barriers.

Mesh:

Year:  2012        PMID: 23113439     DOI: 10.7205/milmed-d-11-00286

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  3 in total

1.  Mental Health Difficulties and Help-Seeking Beliefs within a Sample of Female Partners of UK Veterans Diagnosed with Post-Traumatic Stress Disorder.

Authors:  Dominic Murphy; Emily Palmer; Walter Busuttil
Journal:  J Clin Med       Date:  2016-08-01       Impact factor: 4.241

2.  Acceptability of mental health stigma-reduction training and initial effects on awareness among military personnel.

Authors:  Suzanne L Hurtado; Cynthia M Simon-Arndt; Jennifer McAnany; Jenny A Crain
Journal:  Springerplus       Date:  2015-10-13

3.  Symptom Severity, Self-efficacy and Treatment-Seeking for Mental Health Among US Iraq/Afghanistan Military Veterans.

Authors:  Mary Keeling; Nicholas Barr; Hazel Atuel; Carl A Castro
Journal:  Community Ment Health J       Date:  2020-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.